nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—PLA2G4A—Epirubicin—stomach cancer	0.697	1	CbGbCtD
Fluocinolone Acetonide—PLA2G4A—Raltitrexed—Methotrexate—stomach cancer	0.00584	1	CbGdCrCtD
Fluocinolone Acetonide—Amcinonide—ANXA1—stomach cancer	0.0023	0.561	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—hematopoietic system—stomach cancer	0.00226	0.107	CbGeAlD
Fluocinolone Acetonide—SERPINA6—hematopoietic system—stomach cancer	0.00225	0.107	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—smooth muscle tissue—stomach cancer	0.00199	0.0944	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—bone marrow—stomach cancer	0.00145	0.0687	CbGeAlD
Fluocinolone Acetonide—SERPINA6—bone marrow—stomach cancer	0.00144	0.0684	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—endocrine gland—stomach cancer	0.0013	0.0616	CbGeAlD
Fluocinolone Acetonide—SERPINA6—endocrine gland—stomach cancer	0.00129	0.0613	CbGeAlD
Fluocinolone Acetonide—SERPINA6—liver—stomach cancer	0.00116	0.0553	CbGeAlD
Fluocinolone Acetonide—NR3C1—hematopoietic system—stomach cancer	0.000984	0.0468	CbGeAlD
Fluocinolone Acetonide—NR3C1—epithelium—stomach cancer	0.0009	0.0427	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—lymph node—stomach cancer	0.000897	0.0426	CbGeAlD
Fluocinolone Acetonide—NR3C1—smooth muscle tissue—stomach cancer	0.000867	0.0412	CbGeAlD
Fluocinolone Acetonide—NR3C1—pancreas—stomach cancer	0.000802	0.0381	CbGeAlD
Fluocinolone Acetonide—Dexamethasone—ANXA1—stomach cancer	0.000723	0.176	CrCbGaD
Fluocinolone Acetonide—NR3C1—lymphoid tissue—stomach cancer	0.000693	0.0329	CbGeAlD
Fluocinolone Acetonide—NR3C1—digestive system—stomach cancer	0.000685	0.0325	CbGeAlD
Fluocinolone Acetonide—NR3C1—bone marrow—stomach cancer	0.000631	0.03	CbGeAlD
Fluocinolone Acetonide—NR3C1—endocrine gland—stomach cancer	0.000566	0.0269	CbGeAlD
Fluocinolone Acetonide—Infestation NOS—Fluorouracil—stomach cancer	0.000542	0.00305	CcSEcCtD
Fluocinolone Acetonide—Infestation—Fluorouracil—stomach cancer	0.000542	0.00305	CcSEcCtD
Fluocinolone Acetonide—Visual disturbance—Docetaxel—stomach cancer	0.000536	0.00302	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Mitomycin—stomach cancer	0.000529	0.00298	CcSEcCtD
Fluocinolone Acetonide—Rash—Mitomycin—stomach cancer	0.000524	0.00295	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Mitomycin—stomach cancer	0.000524	0.00295	CcSEcCtD
Fluocinolone Acetonide—Viral infection—Epirubicin—stomach cancer	0.000522	0.00294	CcSEcCtD
Fluocinolone Acetonide—Headache—Mitomycin—stomach cancer	0.000521	0.00293	CcSEcCtD
Fluocinolone Acetonide—Herpes simplex—Epirubicin—stomach cancer	0.000512	0.00288	CcSEcCtD
Fluocinolone Acetonide—Lacrimation increased—Epirubicin—stomach cancer	0.000512	0.00288	CcSEcCtD
Fluocinolone Acetonide—NR3C1—liver—stomach cancer	0.00051	0.0242	CbGeAlD
Fluocinolone Acetonide—Rhinitis—Irinotecan—stomach cancer	0.000509	0.00287	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Fluorouracil—stomach cancer	0.000509	0.00287	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Docetaxel—stomach cancer	0.000508	0.00286	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Irinotecan—stomach cancer	0.000499	0.00281	CcSEcCtD
Fluocinolone Acetonide—Nausea—Mitomycin—stomach cancer	0.000494	0.00278	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Capecitabine—stomach cancer	0.000492	0.00277	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Capecitabine—stomach cancer	0.000492	0.00277	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Irinotecan—stomach cancer	0.00049	0.00276	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Fluorouracil—stomach cancer	0.000488	0.00275	CcSEcCtD
Fluocinolone Acetonide—Viral infection—Doxorubicin—stomach cancer	0.000483	0.00272	CcSEcCtD
Fluocinolone Acetonide—Neck pain—Epirubicin—stomach cancer	0.000478	0.00269	CcSEcCtD
Fluocinolone Acetonide—Lacrimation increased—Doxorubicin—stomach cancer	0.000474	0.00267	CcSEcCtD
Fluocinolone Acetonide—Herpes simplex—Doxorubicin—stomach cancer	0.000474	0.00267	CcSEcCtD
Fluocinolone Acetonide—Dermatitis contact—Epirubicin—stomach cancer	0.000466	0.00263	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Irinotecan—stomach cancer	0.000458	0.00258	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Docetaxel—stomach cancer	0.000454	0.00256	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Irinotecan—stomach cancer	0.000449	0.00253	CcSEcCtD
Fluocinolone Acetonide—Neck pain—Doxorubicin—stomach cancer	0.000442	0.00249	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Capecitabine—stomach cancer	0.00044	0.00248	CcSEcCtD
Fluocinolone Acetonide—Dry eye—Epirubicin—stomach cancer	0.000436	0.00245	CcSEcCtD
Fluocinolone Acetonide—Dermatitis contact—Doxorubicin—stomach cancer	0.000431	0.00243	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Fluorouracil—stomach cancer	0.00043	0.00242	CcSEcCtD
Fluocinolone Acetonide—Back pain—Irinotecan—stomach cancer	0.000428	0.00241	CcSEcCtD
Fluocinolone Acetonide—Influenza—Capecitabine—stomach cancer	0.000425	0.00239	CcSEcCtD
Fluocinolone Acetonide—Erythema—Fluorouracil—stomach cancer	0.000424	0.00239	CcSEcCtD
Fluocinolone Acetonide—Dry eye—Doxorubicin—stomach cancer	0.000403	0.00227	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Fluorouracil—stomach cancer	0.000399	0.00225	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Irinotecan—stomach cancer	0.000397	0.00224	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Capecitabine—stomach cancer	0.000395	0.00222	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Docetaxel—stomach cancer	0.000391	0.0022	CcSEcCtD
Fluocinolone Acetonide—Infestation—Docetaxel—stomach cancer	0.000391	0.0022	CcSEcCtD
Fluocinolone Acetonide—NR3C1—lymph node—stomach cancer	0.000391	0.0186	CbGeAlD
Fluocinolone Acetonide—Prednisolone—CYP2A6—stomach cancer	0.000389	0.0949	CrCbGaD
Fluocinolone Acetonide—Visual disturbance—Methotrexate—stomach cancer	0.000386	0.00218	CcSEcCtD
Fluocinolone Acetonide—Cough—Irinotecan—stomach cancer	0.000386	0.00217	CcSEcCtD
Fluocinolone Acetonide—Eczema—Epirubicin—stomach cancer	0.000381	0.00215	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Epirubicin—stomach cancer	0.000379	0.00214	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Capecitabine—stomach cancer	0.000379	0.00213	CcSEcCtD
Fluocinolone Acetonide—Infestation—Capecitabine—stomach cancer	0.000379	0.00213	CcSEcCtD
Fluocinolone Acetonide—Oedema—Irinotecan—stomach cancer	0.000361	0.00203	CcSEcCtD
Fluocinolone Acetonide—Infection—Irinotecan—stomach cancer	0.000359	0.00202	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Irinotecan—stomach cancer	0.000354	0.00199	CcSEcCtD
Fluocinolone Acetonide—Eczema—Doxorubicin—stomach cancer	0.000353	0.00199	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Docetaxel—stomach cancer	0.000352	0.00198	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Doxorubicin—stomach cancer	0.000351	0.00198	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Epirubicin—stomach cancer	0.000351	0.00198	CcSEcCtD
Fluocinolone Acetonide—Oedema—Fluorouracil—stomach cancer	0.000346	0.00195	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Docetaxel—stomach cancer	0.000345	0.00194	CcSEcCtD
Fluocinolone Acetonide—Infection—Fluorouracil—stomach cancer	0.000343	0.00194	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Epirubicin—stomach cancer	0.000342	0.00193	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Epirubicin—stomach cancer	0.000342	0.00193	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Capecitabine—stomach cancer	0.000341	0.00192	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Fluorouracil—stomach cancer	0.000339	0.00191	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Docetaxel—stomach cancer	0.000338	0.00191	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Capecitabine—stomach cancer	0.000334	0.00188	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Docetaxel—stomach cancer	0.000328	0.00185	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Capecitabine—stomach cancer	0.000328	0.00185	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Doxorubicin—stomach cancer	0.000325	0.00183	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Capecitabine—stomach cancer	0.000318	0.00179	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Doxorubicin—stomach cancer	0.000317	0.00179	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Doxorubicin—stomach cancer	0.000317	0.00179	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Docetaxel—stomach cancer	0.000317	0.00178	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000315	0.00177	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000312	0.00176	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Docetaxel—stomach cancer	0.00031	0.00175	CcSEcCtD
Fluocinolone Acetonide—Pain—Irinotecan—stomach cancer	0.000309	0.00174	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Docetaxel—stomach cancer	0.000308	0.00173	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Capecitabine—stomach cancer	0.000306	0.00173	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Epirubicin—stomach cancer	0.000306	0.00173	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Docetaxel—stomach cancer	0.000306	0.00172	CcSEcCtD
Fluocinolone Acetonide—Erythema—Docetaxel—stomach cancer	0.000306	0.00172	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Capecitabine—stomach cancer	0.000301	0.00169	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Docetaxel—stomach cancer	0.000299	0.00169	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000298	0.00168	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Capecitabine—stomach cancer	0.000298	0.00168	CcSEcCtD
Fluocinolone Acetonide—Erythema—Capecitabine—stomach cancer	0.000296	0.00167	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Capecitabine—stomach cancer	0.000296	0.00167	CcSEcCtD
Fluocinolone Acetonide—Influenza—Epirubicin—stomach cancer	0.000296	0.00167	CcSEcCtD
Fluocinolone Acetonide—Back pain—Docetaxel—stomach cancer	0.000296	0.00167	CcSEcCtD
Fluocinolone Acetonide—Pain—Fluorouracil—stomach cancer	0.000296	0.00167	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Methotrexate—stomach cancer	0.000294	0.00166	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Capecitabine—stomach cancer	0.00029	0.00163	CcSEcCtD
Fluocinolone Acetonide—Back pain—Capecitabine—stomach cancer	0.000286	0.00161	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Irinotecan—stomach cancer	0.000285	0.00161	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Doxorubicin—stomach cancer	0.000283	0.0016	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Methotrexate—stomach cancer	0.000282	0.00159	CcSEcCtD
Fluocinolone Acetonide—Infestation—Methotrexate—stomach cancer	0.000282	0.00159	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Capecitabine—stomach cancer	0.000279	0.00157	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000275	0.00155	CcSEcCtD
Fluocinolone Acetonide—Influenza—Doxorubicin—stomach cancer	0.000274	0.00154	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Fluorouracil—stomach cancer	0.000273	0.00154	CcSEcCtD
Fluocinolone Acetonide—Cough—Docetaxel—stomach cancer	0.000267	0.0015	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Capecitabine—stomach cancer	0.000266	0.0015	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Irinotecan—stomach cancer	0.000266	0.0015	CcSEcCtD
Fluocinolone Acetonide—Infestation—Epirubicin—stomach cancer	0.000264	0.00149	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Epirubicin—stomach cancer	0.000264	0.00149	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Docetaxel—stomach cancer	0.00026	0.00147	CcSEcCtD
Fluocinolone Acetonide—Cough—Capecitabine—stomach cancer	0.000258	0.00146	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Fluorouracil—stomach cancer	0.000255	0.00144	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000255	0.00143	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Capecitabine—stomach cancer	0.000252	0.00142	CcSEcCtD
Fluocinolone Acetonide—Oedema—Docetaxel—stomach cancer	0.00025	0.00141	CcSEcCtD
Fluocinolone Acetonide—Infection—Docetaxel—stomach cancer	0.000248	0.0014	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Epirubicin—stomach cancer	0.000248	0.00139	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Irinotecan—stomach cancer	0.000247	0.00139	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Docetaxel—stomach cancer	0.000245	0.00138	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Fluorouracil—stomach cancer	0.000245	0.00138	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Doxorubicin—stomach cancer	0.000244	0.00138	CcSEcCtD
Fluocinolone Acetonide—Infestation—Doxorubicin—stomach cancer	0.000244	0.00138	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Methotrexate—stomach cancer	0.000244	0.00137	CcSEcCtD
Fluocinolone Acetonide—Oedema—Capecitabine—stomach cancer	0.000242	0.00136	CcSEcCtD
Fluocinolone Acetonide—Infection—Capecitabine—stomach cancer	0.00024	0.00135	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Irinotecan—stomach cancer	0.000239	0.00134	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Epirubicin—stomach cancer	0.000238	0.00134	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Capecitabine—stomach cancer	0.000237	0.00133	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Methotrexate—stomach cancer	0.000237	0.00133	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Fluorouracil—stomach cancer	0.000237	0.00133	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Epirubicin—stomach cancer	0.000233	0.00131	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Irinotecan—stomach cancer	0.00023	0.00129	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Doxorubicin—stomach cancer	0.000229	0.00129	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Fluorouracil—stomach cancer	0.000229	0.00129	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Epirubicin—stomach cancer	0.000228	0.00129	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Methotrexate—stomach cancer	0.000228	0.00129	CcSEcCtD
Fluocinolone Acetonide—Rash—Irinotecan—stomach cancer	0.000228	0.00128	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Irinotecan—stomach cancer	0.000227	0.00128	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000227	0.00128	CcSEcCtD
Fluocinolone Acetonide—Headache—Irinotecan—stomach cancer	0.000226	0.00127	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Methotrexate—stomach cancer	0.000224	0.00126	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP2A6—stomach cancer	0.000222	0.0541	CrCbGaD
Fluocinolone Acetonide—Mental disorder—Methotrexate—stomach cancer	0.000222	0.00125	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Epirubicin—stomach cancer	0.000221	0.00125	CcSEcCtD
Fluocinolone Acetonide—Erythema—Methotrexate—stomach cancer	0.00022	0.00124	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Methotrexate—stomach cancer	0.00022	0.00124	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.00022	0.00124	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Fluorouracil—stomach cancer	0.00022	0.00124	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Doxorubicin—stomach cancer	0.00022	0.00124	CcSEcCtD
Fluocinolone Acetonide—Rash—Fluorouracil—stomach cancer	0.000218	0.00123	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Fluorouracil—stomach cancer	0.000218	0.00123	CcSEcCtD
Fluocinolone Acetonide—Headache—Fluorouracil—stomach cancer	0.000217	0.00122	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Methotrexate—stomach cancer	0.000216	0.00122	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000215	0.00121	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Doxorubicin—stomach cancer	0.000215	0.00121	CcSEcCtD
Fluocinolone Acetonide—Nausea—Irinotecan—stomach cancer	0.000214	0.00121	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Epirubicin—stomach cancer	0.000214	0.0012	CcSEcCtD
Fluocinolone Acetonide—Pain—Docetaxel—stomach cancer	0.000213	0.0012	CcSEcCtD
Fluocinolone Acetonide—Back pain—Methotrexate—stomach cancer	0.000213	0.0012	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Doxorubicin—stomach cancer	0.000211	0.00119	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Epirubicin—stomach cancer	0.000209	0.00118	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000209	0.00118	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Methotrexate—stomach cancer	0.000208	0.00117	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Epirubicin—stomach cancer	0.000208	0.00117	CcSEcCtD
Fluocinolone Acetonide—Pain—Capecitabine—stomach cancer	0.000207	0.00116	CcSEcCtD
Fluocinolone Acetonide—Erythema—Epirubicin—stomach cancer	0.000206	0.00116	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Epirubicin—stomach cancer	0.000206	0.00116	CcSEcCtD
Fluocinolone Acetonide—Nausea—Fluorouracil—stomach cancer	0.000205	0.00116	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Doxorubicin—stomach cancer	0.000205	0.00115	CcSEcCtD
Fluocinolone Acetonide—Triamcinolone—PTGS2—stomach cancer	0.000204	0.0497	CrCbGaD
Fluocinolone Acetonide—Dysgeusia—Epirubicin—stomach cancer	0.000202	0.00114	CcSEcCtD
Fluocinolone Acetonide—Back pain—Epirubicin—stomach cancer	0.000199	0.00112	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Methotrexate—stomach cancer	0.000198	0.00112	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Doxorubicin—stomach cancer	0.000198	0.00111	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Docetaxel—stomach cancer	0.000197	0.00111	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Epirubicin—stomach cancer	0.000194	0.00109	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Doxorubicin—stomach cancer	0.000194	0.00109	CcSEcCtD
Fluocinolone Acetonide—Cough—Methotrexate—stomach cancer	0.000192	0.00108	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Doxorubicin—stomach cancer	0.000192	0.00108	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Capecitabine—stomach cancer	0.000191	0.00108	CcSEcCtD
Fluocinolone Acetonide—Erythema—Doxorubicin—stomach cancer	0.000191	0.00108	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Doxorubicin—stomach cancer	0.000191	0.00108	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Methotrexate—stomach cancer	0.000188	0.00106	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Doxorubicin—stomach cancer	0.000187	0.00105	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Epirubicin—stomach cancer	0.000185	0.00104	CcSEcCtD
Fluocinolone Acetonide—Back pain—Doxorubicin—stomach cancer	0.000185	0.00104	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Docetaxel—stomach cancer	0.000184	0.00104	CcSEcCtD
Fluocinolone Acetonide—Cough—Epirubicin—stomach cancer	0.00018	0.00101	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Doxorubicin—stomach cancer	0.00018	0.00101	CcSEcCtD
Fluocinolone Acetonide—Infection—Methotrexate—stomach cancer	0.000179	0.00101	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Capecitabine—stomach cancer	0.000178	0.001	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Docetaxel—stomach cancer	0.000177	0.000995	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Methotrexate—stomach cancer	0.000176	0.000994	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Epirubicin—stomach cancer	0.000176	0.000989	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Doxorubicin—stomach cancer	0.000171	0.000966	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Capecitabine—stomach cancer	0.000171	0.000963	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Docetaxel—stomach cancer	0.000171	0.000962	CcSEcCtD
Fluocinolone Acetonide—Oedema—Epirubicin—stomach cancer	0.000168	0.000948	CcSEcCtD
Fluocinolone Acetonide—Infection—Epirubicin—stomach cancer	0.000167	0.000942	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—PTGS2—stomach cancer	0.000167	0.0407	CrCbGaD
Fluocinolone Acetonide—Cough—Doxorubicin—stomach cancer	0.000167	0.000938	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Capecitabine—stomach cancer	0.000165	0.000931	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Epirubicin—stomach cancer	0.000165	0.00093	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Docetaxel—stomach cancer	0.000165	0.00093	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000164	0.000923	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Doxorubicin—stomach cancer	0.000162	0.000915	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Capecitabine—stomach cancer	0.00016	0.0009	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Docetaxel—stomach cancer	0.000159	0.000894	CcSEcCtD
Fluocinolone Acetonide—Rash—Docetaxel—stomach cancer	0.000157	0.000886	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Docetaxel—stomach cancer	0.000157	0.000886	CcSEcCtD
Fluocinolone Acetonide—Headache—Docetaxel—stomach cancer	0.000156	0.000881	CcSEcCtD
Fluocinolone Acetonide—Oedema—Doxorubicin—stomach cancer	0.000156	0.000877	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000155	0.000875	CcSEcCtD
Fluocinolone Acetonide—Infection—Doxorubicin—stomach cancer	0.000155	0.000872	CcSEcCtD
Fluocinolone Acetonide—Pain—Methotrexate—stomach cancer	0.000154	0.000866	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Capecitabine—stomach cancer	0.000154	0.000865	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000153	0.000864	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Doxorubicin—stomach cancer	0.000153	0.00086	CcSEcCtD
Fluocinolone Acetonide—Rash—Capecitabine—stomach cancer	0.000152	0.000858	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Capecitabine—stomach cancer	0.000152	0.000857	CcSEcCtD
Fluocinolone Acetonide—Headache—Capecitabine—stomach cancer	0.000151	0.000853	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	0.000149	0.00157	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Docetaxel—stomach cancer	0.000148	0.000835	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—RORA—stomach cancer	0.000146	0.00153	CbGpPWpGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000145	0.000819	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—APOA1—stomach cancer	0.000145	0.00153	CbGpPWpGaD
Fluocinolone Acetonide—Pain—Epirubicin—stomach cancer	0.000144	0.000811	CcSEcCtD
Fluocinolone Acetonide—Nausea—Capecitabine—stomach cancer	0.000144	0.000808	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—stomach cancer	0.000143	0.00151	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—JUN—stomach cancer	0.000143	0.0015	CbGpPWpGaD
Fluocinolone Acetonide—Body temperature increased—Methotrexate—stomach cancer	0.000142	0.000801	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000142	0.000799	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—stomach cancer	0.000142	0.00149	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SPARC—stomach cancer	0.000141	0.00148	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—F2R—stomach cancer	0.000141	0.00148	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HRH4—stomach cancer	0.000141	0.00148	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—stomach cancer	0.000139	0.00146	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	0.000138	0.00146	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PRKCB—stomach cancer	0.000138	0.00146	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—PPARG—stomach cancer	0.000138	0.00145	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IRF1—stomach cancer	0.000138	0.00145	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PGLS—stomach cancer	0.000138	0.00145	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—BLVRB—stomach cancer	0.000138	0.00145	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—stomach cancer	0.000137	0.00145	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—MAPK8—stomach cancer	0.000135	0.00142	CbGpPWpGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000134	0.000757	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—stomach cancer	0.000134	0.00141	CbGpPWpGaD
Fluocinolone Acetonide—Pain—Doxorubicin—stomach cancer	0.000133	0.00075	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Epirubicin—stomach cancer	0.000133	0.00075	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Methotrexate—stomach cancer	0.000133	0.000747	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPAP2A—stomach cancer	0.000131	0.00138	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—RARB—stomach cancer	0.00013	0.00137	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—MYC—stomach cancer	0.000129	0.00136	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Methotrexate—stomach cancer	0.000127	0.000717	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	0.000126	0.00133	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—KISS1—stomach cancer	0.000125	0.00132	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HNRNPL—stomach cancer	0.000125	0.00132	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—SERPINE1—stomach cancer	0.000124	0.00131	CbGpPWpGaD
Fluocinolone Acetonide—Hypersensitivity—Epirubicin—stomach cancer	0.000124	0.000699	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—STAT3—stomach cancer	0.000124	0.0013	CbGpPWpGaD
Fluocinolone Acetonide—Body temperature increased—Doxorubicin—stomach cancer	0.000123	0.000694	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Methotrexate—stomach cancer	0.000123	0.000693	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CD44—stomach cancer	0.00012	0.00126	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—EEF1A1—stomach cancer	0.000119	0.00126	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Epirubicin—stomach cancer	0.000119	0.000671	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Methotrexate—stomach cancer	0.000119	0.00067	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—MAPK3—stomach cancer	0.000118	0.00124	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—stomach cancer	0.000117	0.00123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—FBP1—stomach cancer	0.000117	0.00123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CA1—stomach cancer	0.000117	0.00123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NDUFA2—stomach cancer	0.000117	0.00123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CKB—stomach cancer	0.000117	0.00123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	0.000115	0.00122	CbGpPWpGaD
Fluocinolone Acetonide—Diarrhoea—Epirubicin—stomach cancer	0.000115	0.000649	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KISS1R—stomach cancer	0.000115	0.00121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GLI3—stomach cancer	0.000115	0.00121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—SERPINE1—stomach cancer	0.000115	0.00121	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—stomach cancer	0.000115	0.00121	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL6R—stomach cancer	0.000115	0.00121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—MYC—stomach cancer	0.000115	0.00121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—ALB—stomach cancer	0.000115	0.00121	CbGpPWpGaD
Fluocinolone Acetonide—Hypersensitivity—Doxorubicin—stomach cancer	0.000115	0.000646	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Methotrexate—stomach cancer	0.000114	0.000644	CcSEcCtD
Fluocinolone Acetonide—Rash—Methotrexate—stomach cancer	0.000113	0.000639	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Methotrexate—stomach cancer	0.000113	0.000638	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	0.000113	0.00119	CbGpPWpGaD
Fluocinolone Acetonide—Headache—Methotrexate—stomach cancer	0.000113	0.000635	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—MAPK1—stomach cancer	0.000112	0.00118	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—stomach cancer	0.000111	0.00117	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Epirubicin—stomach cancer	0.000111	0.000627	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—RHOA—stomach cancer	0.000111	0.00117	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Doxorubicin—stomach cancer	0.00011	0.000621	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PLIN2—stomach cancer	0.00011	0.00116	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RBP1—stomach cancer	0.00011	0.00116	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—RGS2—stomach cancer	0.000108	0.00114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GAST—stomach cancer	0.000108	0.00114	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Epirubicin—stomach cancer	0.000107	0.000603	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CA2—stomach cancer	0.000107	0.00113	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	0.000107	0.00113	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Methotrexate—stomach cancer	0.000107	0.000602	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Doxorubicin—stomach cancer	0.000107	0.0006	CcSEcCtD
Fluocinolone Acetonide—Rash—Epirubicin—stomach cancer	0.000106	0.000598	CcSEcCtD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TP53—stomach cancer	0.000106	0.00112	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—KRAS—stomach cancer	0.000106	0.00112	CbGpPWpGaD
Fluocinolone Acetonide—Dermatitis—Epirubicin—stomach cancer	0.000106	0.000597	CcSEcCtD
Fluocinolone Acetonide—Headache—Epirubicin—stomach cancer	0.000105	0.000594	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NT5E—stomach cancer	0.000104	0.0011	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PGAM1—stomach cancer	0.000104	0.0011	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—CPSF1—stomach cancer	0.000103	0.00109	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—EXOSC5—stomach cancer	0.000103	0.00109	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Doxorubicin—stomach cancer	0.000103	0.00058	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	0.000102	0.00107	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PPP2R1A—stomach cancer	0.000102	0.00107	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	0.000102	0.00107	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—POLR3K—stomach cancer	0.0001	0.00105	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Epirubicin—stomach cancer	0.0001	0.000563	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALDH7A1—stomach cancer	9.95e-05	0.00105	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PLCE1—stomach cancer	9.95e-05	0.00105	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Doxorubicin—stomach cancer	9.9e-05	0.000558	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	9.86e-05	0.00104	CbGpPWpGaD
Fluocinolone Acetonide—Rash—Doxorubicin—stomach cancer	9.82e-05	0.000553	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Doxorubicin—stomach cancer	9.81e-05	0.000553	CcSEcCtD
Fluocinolone Acetonide—Headache—Doxorubicin—stomach cancer	9.76e-05	0.00055	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—stomach cancer	9.75e-05	0.00103	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—PTGS2—stomach cancer	9.71e-05	0.0237	CrCbGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—IL6—stomach cancer	9.71e-05	0.00102	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	9.63e-05	0.00101	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—UMPS—stomach cancer	9.54e-05	0.001	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—CDKN1A—stomach cancer	9.5e-05	0.001	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—stomach cancer	9.35e-05	0.000984	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Doxorubicin—stomach cancer	9.25e-05	0.000521	CcSEcCtD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—stomach cancer	9.11e-05	0.000959	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—HRAS—stomach cancer	9.02e-05	0.00095	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—PIK3CA—stomach cancer	9.01e-05	0.000948	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—FYN—stomach cancer	8.98e-05	0.000946	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—WWOX—stomach cancer	8.95e-05	0.000942	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	8.89e-05	0.000936	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ECHS1—stomach cancer	8.86e-05	0.000933	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PDHA1—stomach cancer	8.86e-05	0.000933	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL1B—stomach cancer	8.74e-05	0.00092	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RXRB—stomach cancer	8.68e-05	0.000914	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—stomach cancer	8.56e-05	0.000901	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPL13—stomach cancer	8.51e-05	0.000896	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPL18—stomach cancer	8.51e-05	0.000896	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—STAT3—stomach cancer	8.47e-05	0.000892	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—JUN—stomach cancer	8.47e-05	0.000891	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	8.41e-05	0.000886	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—FADS1—stomach cancer	8.33e-05	0.000878	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TYMP—stomach cancer	8.33e-05	0.000878	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HRH4—stomach cancer	8.32e-05	0.000876	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—WIF1—stomach cancer	8.32e-05	0.000876	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	8.18e-05	0.000861	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AGTR2—stomach cancer	8.18e-05	0.000861	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—F2R—stomach cancer	8.09e-05	0.000851	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	8e-05	0.000843	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	8e-05	0.000842	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPS15—stomach cancer	7.94e-05	0.000836	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPS21—stomach cancer	7.94e-05	0.000836	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	7.91e-05	0.000833	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HTR1A—stomach cancer	7.87e-05	0.000829	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SNRPB—stomach cancer	7.81e-05	0.000823	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SREBF2—stomach cancer	7.8e-05	0.000822	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—RORA—stomach cancer	7.71e-05	0.000812	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKAB1—stomach cancer	7.68e-05	0.000808	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PLAU—stomach cancer	7.66e-05	0.000807	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	7.62e-05	0.000802	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ANXA1—stomach cancer	7.6e-05	0.000801	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	7.56e-05	0.000796	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CAV1—stomach cancer	7.49e-05	0.000788	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	7.48e-05	0.000788	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—APOA1—stomach cancer	7.47e-05	0.000786	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KISS1—stomach cancer	7.41e-05	0.000781	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RNF43—stomach cancer	7.41e-05	0.000781	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—stomach cancer	7.4e-05	0.000779	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ADRB1—stomach cancer	7.36e-05	0.000775	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TNF—stomach cancer	7.33e-05	0.000772	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—SMAD4—stomach cancer	7.25e-05	0.000763	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALDOB—stomach cancer	7.23e-05	0.000761	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PRKCB—stomach cancer	7.12e-05	0.00075	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	7.12e-05	0.00075	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RORA—stomach cancer	7.02e-05	0.000739	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	6.94e-05	0.000731	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	6.81e-05	0.000718	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	6.8e-05	0.000716	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALOX5—stomach cancer	6.72e-05	0.000707	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	6.72e-05	0.000707	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—DPYD—stomach cancer	6.61e-05	0.000696	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FST—stomach cancer	6.61e-05	0.000696	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—DNMT3B—stomach cancer	6.58e-05	0.000692	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HBEGF—stomach cancer	6.46e-05	0.000681	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPL15—stomach cancer	6.45e-05	0.000679	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RGS2—stomach cancer	6.37e-05	0.000671	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GAST—stomach cancer	6.37e-05	0.000671	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TNF—stomach cancer	6.34e-05	0.000667	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RARB—stomach cancer	6.27e-05	0.000661	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	6.18e-05	0.000651	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGG—stomach cancer	6.04e-05	0.000636	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPS26—stomach cancer	6.01e-05	0.000633	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.99e-05	0.000631	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ADRB2—stomach cancer	5.97e-05	0.000628	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SERPINE1—stomach cancer	5.93e-05	0.000624	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IL6—stomach cancer	5.92e-05	0.000623	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ALB—stomach cancer	5.92e-05	0.000623	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PPP2R1A—stomach cancer	5.85e-05	0.000616	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTT1—stomach cancer	5.84e-05	0.000615	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKAA1—stomach cancer	5.82e-05	0.000612	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP2A6—stomach cancer	5.78e-05	0.000608	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—RHOA—stomach cancer	5.72e-05	0.000602	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS3—stomach cancer	5.66e-05	0.000596	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKR1C3—stomach cancer	5.62e-05	0.000592	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RBP4—stomach cancer	5.62e-05	0.000592	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ENO1—stomach cancer	5.48e-05	0.000577	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.39e-05	0.000567	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HSPB1—stomach cancer	5.26e-05	0.000554	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL6—stomach cancer	5.12e-05	0.000539	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPS19—stomach cancer	5.11e-05	0.000538	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—PPARG—stomach cancer	5.04e-05	0.000531	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—DNMT1—stomach cancer	4.89e-05	0.000515	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CD44—stomach cancer	4.86e-05	0.000511	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HSPB1—stomach cancer	4.83e-05	0.000509	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AGTR2—stomach cancer	4.83e-05	0.000509	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HSPA8—stomach cancer	4.82e-05	0.000507	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BMP2—stomach cancer	4.78e-05	0.000503	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—F2R—stomach cancer	4.78e-05	0.000503	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.71e-05	0.000496	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKR1C3—stomach cancer	4.7e-05	0.000495	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HTR1A—stomach cancer	4.65e-05	0.00049	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—SERPINE1—stomach cancer	4.54e-05	0.000478	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPS6—stomach cancer	4.52e-05	0.000476	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ANXA1—stomach cancer	4.49e-05	0.000473	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADRB1—stomach cancer	4.35e-05	0.000458	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RPS6—stomach cancer	4.16e-05	0.000438	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPP2R1A—stomach cancer	4.13e-05	0.000435	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PRKCB—stomach cancer	4.09e-05	0.000431	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VEGFA—stomach cancer	4.08e-05	0.000429	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6ST—stomach cancer	4.07e-05	0.000429	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTP1—stomach cancer	4.05e-05	0.000427	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HMOX1—stomach cancer	4e-05	0.000421	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MAPK3—stomach cancer	3.86e-05	0.000406	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HBEGF—stomach cancer	3.82e-05	0.000402	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TYMS—stomach cancer	3.77e-05	0.000397	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPP2R1A—stomach cancer	3.76e-05	0.000396	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTM1—stomach cancer	3.72e-05	0.000392	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MAPK1—stomach cancer	3.67e-05	0.000386	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6R—stomach cancer	3.63e-05	0.000383	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADRB2—stomach cancer	3.52e-05	0.000371	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ERCC2—stomach cancer	3.5e-05	0.000369	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SMAD4—stomach cancer	3.49e-05	0.000367	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—KRAS—stomach cancer	3.47e-05	0.000365	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PPP2R1A—stomach cancer	3.45e-05	0.000364	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MTHFR—stomach cancer	3.29e-05	0.000346	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—RHOA—stomach cancer	3.28e-05	0.000346	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SMAD4—stomach cancer	3.21e-05	0.000338	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ERCC2—stomach cancer	3.18e-05	0.000335	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CA—stomach cancer	3.18e-05	0.000335	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TP53—stomach cancer	3.08e-05	0.000324	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FYN—stomach cancer	3.04e-05	0.000321	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CAV1—stomach cancer	3.03e-05	0.00032	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOA1—stomach cancer	3.03e-05	0.000319	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—HRAS—stomach cancer	2.95e-05	0.00031	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.9e-05	0.000305	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCL8—stomach cancer	2.88e-05	0.000303	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—MYC—stomach cancer	2.87e-05	0.000303	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGFR2—stomach cancer	2.86e-05	0.000301	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARG—stomach cancer	2.67e-05	0.000281	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IRS2—stomach cancer	2.62e-05	0.000276	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CAV1—stomach cancer	2.54e-05	0.000267	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOA1—stomach cancer	2.53e-05	0.000267	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPARG—stomach cancer	2.43e-05	0.000256	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKCB—stomach cancer	2.42e-05	0.000254	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6ST—stomach cancer	2.41e-05	0.000253	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALB—stomach cancer	2.4e-05	0.000253	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APC—stomach cancer	2.31e-05	0.000243	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NOS3—stomach cancer	2.29e-05	0.000242	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAPK3—stomach cancer	2.21e-05	0.000233	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SERPINE1—stomach cancer	2.19e-05	0.00023	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6R—stomach cancer	2.15e-05	0.000226	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAPK1—stomach cancer	2.11e-05	0.000222	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EGFR—stomach cancer	2.11e-05	0.000222	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—stomach cancer	2.1e-05	0.000221	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SERPINE1—stomach cancer	2.01e-05	0.000212	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—KRAS—stomach cancer	1.99e-05	0.000209	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RHOA—stomach cancer	1.94e-05	0.000204	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOS3—stomach cancer	1.92e-05	0.000202	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CA—stomach cancer	1.83e-05	0.000192	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ERBB2—stomach cancer	1.79e-05	0.000189	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL8—stomach cancer	1.7e-05	0.000179	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HRAS—stomach cancer	1.69e-05	0.000178	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN1B—stomach cancer	1.66e-05	0.000175	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6—stomach cancer	1.62e-05	0.00017	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCND1—stomach cancer	1.59e-05	0.000167	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JUN—stomach cancer	1.58e-05	0.000167	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP9—stomach cancer	1.54e-05	0.000162	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN1A—stomach cancer	1.53e-05	0.000162	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK8—stomach cancer	1.5e-05	0.000158	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MAPK3—stomach cancer	1.42e-05	0.00015	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MYC—stomach cancer	1.38e-05	0.000146	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFA—stomach cancer	1.38e-05	0.000146	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STAT3—stomach cancer	1.37e-05	0.000144	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK3—stomach cancer	1.31e-05	0.000138	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CA—stomach cancer	1.29e-05	0.000136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MYC—stomach cancer	1.27e-05	0.000134	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK1—stomach cancer	1.24e-05	0.000131	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EGFR—stomach cancer	1.24e-05	0.000131	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KRAS—stomach cancer	1.18e-05	0.000124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CA—stomach cancer	1.08e-05	0.000114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TP53—stomach cancer	1.04e-05	0.00011	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HRAS—stomach cancer	9.99e-06	0.000105	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6—stomach cancer	9.56e-06	0.000101	CbGpPWpGaD
